Type 2 diabetes.

Ahmad, Ehtasham; Lim, Soo; Lamptey, Roberta; Webb, David R; Davies, Melanie J

Type 2 diabetes.

Ahmad, Ehtasham; Lim, Soo; Lamptey, Roberta; Webb, David R; Davies, Melanie J.

Afiliación

Ahmad E; Diabetes Research Centre, University of Leicester and the Leicester NIHR Biomedical Research Centre, Leicester General Hospital, Leicester, UK.
Lim S; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
Lamptey R; Family Medicine Department, Korle Bu Teaching Hospital, Accra Ghana and Community Health Department, University of Ghana Medical School, Accra, Ghana.
Webb DR; Diabetes Research Centre, University of Leicester and the Leicester NIHR Biomedical Research Centre, Leicester General Hospital, Leicester, UK.
Davies MJ; Diabetes Research Centre, University of Leicester and the Leicester NIHR Biomedical Research Centre, Leicester General Hospital, Leicester, UK. Electronic address: melanie.davies@uhl-tr.nhs.uk.

Lancet ; 400(10365): 1803-1820, 2022 11 19.

Article en En | MEDLINE | ID: mdl-36332637

Asunto(s)

Diabetes Mellitus Tipo 2; Epidemias; Humanos; Niño; Adulto Joven; Adulto; Diabetes Mellitus Tipo 2/tratamiento farmacológico; Diabetes Mellitus Tipo 2/epidemiología; Farmacogenética; Medicina de Precisión; Tecnología

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Epidemias Tipo de estudio: Prognostic_studies / Screening_studies Límite: Adult / Child / Humans Idioma: En Revista: Lancet Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google